DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and more than 2,300 generic ingredients from more than 1,700 branded and generic pharmaceutical companies, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.
Summary for Generic Name: methylphenidate
Clinical Trials for: methylphenidate
A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers
Status: Completed Condition: Pharmacokinetics
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
Status: Terminated Condition: Brain Tumor
A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
Status: Recruiting Condition: HIV Dementia
Methylphenidate Study in Breast or Gastrointestinal Cancer Patients
Status: Active, not recruiting Condition: Breast Cancer; Fatigue; Gastrointestinal Cancer
Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients
Status: Terminated Condition: Asthenia; Neoplasms
An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder
Status: Completed Condition: Attention Deficit Hyperactivity Disorder
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Product||Substance||Delist_Flag||Patent Expiration||Patented / Exclusive Use|
|TABLET; ORAL||010187||Approved Prior to Jan 1, 1982||RX||No||<disabled>|
|TABLET; ORAL||010187||Approved Prior to Jan 1, 1982||RX||Yes||<disabled>|
|TABLET; ORAL||040220||Aug 29, 1997||RX||No||<disabled>|
|TABLET; ORAL||086429||Approved Prior to Jan 1, 1982||RX||No||<disabled>|
|The preview shows a limited data set. Complete access is available with a Subscription|
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639`abc